AIM
PGNX

Ada Investment Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Ada Investment Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-31,709
Closed -$180K – 587
2015
Q3 		$180K Buy
+31,709
New +$243K 0.09% 421

Other funds holding PGNX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ada Investment Management's PGNX Position: Q4 2015 in Review

Ada Investment Management sold out of Progenics Pharmaceuticals Inc (PGNX) in Q4 2015, closing a stake of 31,709 shares — an estimated $180K sold.

Ada Investment Management first reported a position in PGNX in Q3 2015 and held it in 1 quarter. The position peaked at $180K in Q3 2015. 121 funds tracked by Wall St. Rank hold PGNX as of Q4 2015.

  • Ada Investment Management reported no remaining Progenics Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Ada Investment Management sold 31,709 Progenics Pharmaceuticals Inc shares in Q4 2015, an estimated $180K.
  • Ada Investment Management first reported a position in Progenics Pharmaceuticals Inc in Q3 2015 and held it in 1 quarter.
  • Ada Investment Management's Progenics Pharmaceuticals Inc position peaked at $180K in Q3 2015.
  • 121 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.